At 8:20AM, SGX Nifty was up 12 points at 5789.
According to the technical charts, "The 5,720-5,685 area should be keenly watched for support. In case of a pull-back the index may jump back to 5,800-odd levels. On Thursday, the Nifty may seek support around 5,710-5,695, while face resistance around 5,770-5,790."
Also Read
Among the key Asian indices, Japan’s Nikkei was up 0.6% to 13,749 in the opening deals.
Overnight, US stocks ended flat as the Federal Reserve gave no hint that a reduction in the pace of its bond-buying program is imminent.
The Dow Jones industrial average slipped 21.05 points, or 0.14 percent, to end at 15,499.54. The Standard & Poor's 500 Index dipped 0.23 of a point, or 0.01 percent, to finish at 1,685.73.
In contrast, the Nasdaq Composite Index rose 9.90 points, or 0.27 percent, to close at 3,626.37.
Domestically, in the earnings calendar we have Adani Ports, Adani Power, Bank of Baroda, Ceat, Idea Cellular, J&K Bank, Mangalore Chemicals, Power Grid Corp, Jubilant Life Sciences, Reliance Communications, Tata Teleservices, Tata Global, Titan Industries and Union Bank set to unveil their first quarter results later today.
Following stocks are expected to move on the exchanges today:
Consolidated net loss of Jubilant Industries widened to Rs 16.96 crore in the first quarter ended June 30, 2013. The company had reported net loss of Rs 6.89 crore in the April-June quarter of last fiscal.
Mangalore-based private sector lender Karnataka Bank today reported 12.87% rise in net profit to Rs 94.17 crore for the first quarter ended June 30, 2013 compared to Rs 83.43 crore reported in the same quarter last fiscal.
Buoyed by a strong revenue growth and a favourable currency, HCL Technologies Ltd reported a 41.6% jump in net profit at Rs 1,210 crore for the quarter ended 30 June compared to the same period last year. The country's fourth largest software service firm’s revenues during the quarter grew by 17.3% year-on-year at Rs 6,944 crore.
Drug firm Lupin today said the company's US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsules from the US health regulator.
JSW Steel has reported a consolidated net loss of Rs 382 crore in the first quarter ended June 30, 2013 compared to a net profit of Rs 50 crore in the corresponding period last fiscal. Higher raw material costs and lack of demand for steel products impacted the
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)